Methodology for the in vitro evaluation of the delivery efficiency from valved holding chambers with facemasks

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 27, Issue SUPPL. 1, 2014, Pages

  Xu, Zhen ^a   Hsu, Wenchi ^a   Von Hollen, Dirk ^b   Viswanath, Ashwin ^c   Nikander, Kurt ^d   Dalby, Richard ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b PHILIPS RESEARCH LABORATORIES   (Germany)

^c PHILIPS HEALTHCARE   (United States)

^d InDevCo AB   (Sweden)

Author keywords

aerosol drug therapy; anatomical models; facemasks; in vitro; metered dose inhalers; seal leakage; spacer inhalers; valved holding chambers

Indexed keywords

SILICONE; AEROSOL; SALBUTAMOL;

ANATOMIC MODEL; ANTISTATIC VALVED HOLDING CHAMBER; ARTICLE; BREATHING PATTERN; DRUG DELIVERY DEVICE; EQUIPMENT FAILURE; FACE MASK; FACEMASK SEAL; FACEMASK SEAL LEAKAGE; FILTER; FLOWMETER; HUMAN; IN VITRO STUDY; INHALATION SPACER; METERED DOSE INHALER; METHODOLOGY; NON ANTISTATIC VALVED HOLDING CHAMBER; PEDIATRIC FACE MASK; PUMP; SIMULATOR; VACUUM PUMP; VALVED HOLDING CHAMBER; AEROSOL; AGE; ANATOMY AND HISTOLOGY; AUDIOVISUAL EQUIPMENT; BREATHING RATE; CHEMISTRY; COMPARATIVE STUDY; DEVICES; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; FACE; FLOW KINETICS; INHALATION; INHALATIONAL DRUG ADMINISTRATION; MALE; MASK; PARTICLE SIZE; PRESCHOOL CHILD; PRESSURE; TIME;

ADMINISTRATION, INHALATION; AEROSOLS; AGE FACTORS; ALBUTEROL; CHILD, PRESCHOOL; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FACE; HUMANS; INHALATION; MALE; MASKS; METERED DOSE INHALERS; MODELS, ANATOMIC; PARTICLE SIZE; PRESSURE; RESPIRATORY RATE; RHEOLOGY; TIME FACTORS;

EID: 84904822795     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2013.1074     Document Type: Article

References (31)

1. Newman SP: Spacer Devices for metered dose inhalers. Clin Pharmacokinet. 2004;43:349-360. (Pubitemid 38594710)
2. National Asthma Education and Prevention Program (US): Expert panel report 3: guiDelines for the diagnosis and management of asthma-full report 2007 (EPR-3 full report 2007). U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute (US), Bethesda, MD; 2007.
3. British Thoracic Society Scottish Intercollegiate GuiDelines Network (UK): British guiDeline on the management of asthma. Thorax. 2008;63(Suppl 4):iv1-iv121.
4. Hsu W, Xu Z, Von Hollen D, Bai T, NikanDer K, and Dalby R: Evaluation of Delivery efficiency from valved holding chambers with facemasks unDer simulated use conditions. In: Dalby RN, Byron PR, Peart J, Suman JD, and Young PM (eds). RDD Europe 2011. Proceedings of Respiratory Drug Delivery Europe 2011; May 3-6, 2011; Berlin, Germany. Virginia Commonwealth University, Richmond, VA; vol. 2, pp. 505-510, 2011.
5. Amirav I, and Newhouse MT: Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics. 2001;108:389-394.
6. Smaldone GC, Berg E, and NikanDer K: Variation in pediatric aerosol Delivery: importance of facemask. J Aerosol Med. 2005;18:354-363. (Pubitemid 41395736)
7. Erzinger S, Schueepp KG, Brooks-Wildhaber J, Devadason SG, and Wildhaber JH: Facemasks and aerosol Delivery in vivo. J Aerosol Med. 2007;20(Suppl 1)S78-S83; discussion S83-S84. (Pubitemid 46685088)
8. Morton RW, and Mitchell JP: Design of facemasks for Delivery of aerosol-based medication via pressurized metered dose inhaler with valved holding chamber: key issues that affect performance. J Aerosol Med. 2007;20(Suppl 1):S29-S42; discussion S42-S45. (Pubitemid 46685080)
9. Amirav I, and Newhouse MT: Review of optimal characteristics of face-masks for valved-holding chambers (VHCs). Pediatr Pulmonol. 2008;43:268-274. (Pubitemid 351374459)
10. Shah SA, Berlinski AB, and Rubin BK: Force-DepenDent static Dead space of face masks used with holding chambers. Respir Care. 2006;51:140-144. (Pubitemid 46888412)
11. Schultz A, Le Souef TJ, Looi K, Zhang G, Le Souef PN, and Devadason SG: Validation of methodology for recording breathing and simulating drug Delivery through spacers and valved holding chambers. J Aerosol Med Pulm Drug Deliv. 2010;23:311-322.
12. DiBlasi RM, Coppolo DP, Nagel MW, Doyle CC, Avvakoumova VI, Ali RS, and Mitchell JP: A novel, versatile valved holding chamber for Delivering inhaled medications to neonates and small children: laboratory simulation of Delivery options. Respir Care. 2010;55:419-426.
13. Kamin W, and Ehlich H: In vitro comparison of output and particle size distribution of buDesoniDe from metered-dose inhaler with three spacer Devices during pediatric tidal breathing. Treat Respir Med. 2006;5:503-508. (Pubitemid 44968307)
14. Mitchell JP: Appropriate face moDels for evaluating drug Delivery in the laboratory: The current situation and prospects for future adVances. J Aerosol Med Pulm Drug Deliv. 2008;21:97-112.
15. Everard ML, Clark AR, and Milner AD: Drug Delivery from holding chambers with attached facemask. Arch Dis Child. 1992;67:580-585.
16. Finlay WH, and Zuberbuhler P: In vitro comparison of beclomethasone and salbutamol metered-dose inhaler aerosols inhaled during pediatric tidal breathing from four valved holding chambers. Chest. 1998;114:1676-1680. (Pubitemid 128487492)
17. Finlay WH, and Zuberbuhler P: In vitro comparison of salbutamol hydrofluoroalkane (Airomir) metered dose inhaler aerosols inhaled during pediatric tidal breathing from five valved holding chambers. J Aerosol Med. 1999;12:285-291.
18. Sangwan S, Gurses BK, and Smaldone GC: Facemasks and facial Deposition of aerosols. Pediatr Pulmonol. 2004;37:447-452. (Pubitemid 38620068)
19. Esposito-Festen JE, Ates B, Van Vliet FJM, Verbraak AFM, De Jongste JC, and TidDens HAWM: Effect of a facemask leak on aerosol Delivery from a pMDI-spacer system. J Aerosol Med. 2004;17:1-6. (Pubitemid 38520667)
20. NikanDer K, Berg E, and Smaldone GC: Jet nebulizers versus pressurized metered dose inhalers with valved holding chambers: effects of the facemask on aerosol Delivery. J Aerosol Med. 2007;20(Suppl 1):S46-S55; discussion S55-S58. (Pubitemid 46685082)
21. Mitchell JP, Wiersema KJ, MacKay HA, Nagel MW, Pischel SM, and Cripps AL: Novel approach for evaluating medication Delivered via valved holding chambers (VHCs) with facemask using a face moDel for infants and small children. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, and Young PM (eds). Respiratory Drug Delivery 2008. Proceedings of Respiratory Drug Delivery 2008; May 11-15, 2008; Scottsdale, AZ. Virginia Commonwealth University, Richmond, VA; vol. 3, pp. 785-788, 2008.
22. Louca E, Leung K, Coates AL, Mitchell JP, and Nagel MW: Comparison of three valved holding chambers for the Delivery of fluticasone propionate-HFA to an infant face moDel. J Aerosol Med. 2006;19:160-167. (Pubitemid 43993382)
23. Hsu W, Bai T, Von Hollen D, NikanDer K, and Dalby R: Realistic evaluation of a valved holding chamber with facemask- using a soft anatomical moDel face to evaluate aerosol output unDer simulated use conditions. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, and Young PM (eds). Respiratory Drug Delivery 2010. Proceedings of Respiratory Drug Delivery 2010; April 25-29, 2010; Orlando, FL. Virginia Commonwealth University, Richmond, VA; vol. 3, pp. 835-838, 2010.
24. Hsu W, Von Hollen D, Xu Z, Bai T, NikanDer K, and Dalby R: Breath-by-breath Delivered dose comparison from three anti-static valved holding chambers with facemask systems unDer simulated pediatric breathing conditions. Eur Respir J. 2011;38(Suppl 55):884s.
25. Xu Z, Hsu W, Von Hollen D, Viswanath A, NikanDer K, and Dalby R: Delivery efficiency from valved-holding chambers with facemasks: a comparative study using soft anatomical face moDels. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, and Young PM (eds). Respiratory Drug Delivery 2012. Proceedings of Respiratory Drug Delivery 2012; May 13-17, 2012; Phoenix, AZ. Virginia Commonwealth University, Richmond, VA; vol. 3, pp. 809-814, 2012.
26. Von Hollen D, Guzman J, and NikanDer K: Use of an in vitro test rig that mimics multiple aspects of patient use/misuse of valved holding chamber facemasks. J Aerosol Med. 2010;23:426.
27. Von Hollen D, Guzman J, Lieberman E, and NikanDer K: Effect of simulated facial movement on the seal integrity of a valved holding chamber mask. Am J Respir Crit Care Med. 2010;181:A1350.
28. Morton RW, Mitchell JP, and Nagel MW: The case for normalizing in vitro performance data for spacers (S) and valved holding chambers (VHC) to reflect the unDerlying function of the pressurized metered-dose inhaler (pMDI). In: Dalby RN, Byron PR, Peart J, Suman JD, and Farr SJ (eds). Respiratory Drug Delivery 2006. Proceedings of Respiratory Drug Delivery 2006; April 23-27, 2006; Boca Raton, FL. Virginia Commonwealth University, Richmond, VA; vol. 3, pp. 809-812, 2006.
29. HayDen JT, Smith N, Woolf DA, Barry PW, and O'Callaghan C: A randomised crossover trial of facemask efficacy. Arch Dis Child. 2004;89:72-73. (Pubitemid 38122018)
30. Janssens HM, Krijgsman A, Verbraak TF, Hop WC, De Jongste JC, and TidDens HA: Determining factors of aerosol Deposition for four pMDI-spacer combinations in an infant upper airway moDel. J Aerosol Med. 2004;17:51-61. (Pubitemid 38520673)
31. Mitchell JP, Coppolo DP, and Nagel MW: Electrostatics and inhaled medications: influence on Delivery via pressurized metered-dose inhalers and add-on Devices. Respir Care. 2007;52:283-300.